Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background And Aims: Besides hospital size, clinical diagnosis and severity of patient cases determine the total platelet usage. Therefore, the appropriateness of platelet usage could not be compared simply with the total units of platelet usage in each hospital. This study aimed to objectively monitor and analyze platelet usage after implementing a single-unit issuing policy for each platelet transfusion in our hospital in October 2020.
Materials And Methods: We used three objective indices, X, Y, and Z, to monitor platelet usage and compared it with other hospitals. Three indices were generated by dividing the annual total units of platelet usage by the total annual reimbursement, total number of admissions, and average total reimbursement per admission for each hospital.
Results: The new indices X and Y alleviated hospital size-dependent differences. Index Y was preferred over X because its value fluctuated less during the COVID-19 pandemic. The Z index was adjusted for the average total reimbursement per admission, and the results showed that more patients with higher disease complexity did not have increased platelet usage during the COVID-19 pandemic. In our hospital (H1), index Z decreased from 2019 to 2021 due to a policy of issuing a single unit for each platelet transfusion.
Conclusion: These three objective indices are suitable for peer comparison and monitoring platelet usage in hospitals, irrespective of their size. They could be applied to promote patient blood management and provide an early response to the gradual shortage of blood resources owing to the aging population and declining birth rate in Taiwan.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11016628 | PMC |
| http://dx.doi.org/10.1002/hsr2.2032 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
How do I implement a whole blood program with low blood wastage?
Transfusion
September 2025
Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden.
Background: The use of low-titer O whole blood (LTOWB) is requested in the treatment of major bleeding, initially used in military medicine but now increasingly utilized in civilian prehospital care. The advantage is the administration of a balanced transfusion, red blood cells, coagulation factors, and platelets, in one bag. The challenges are the availability of LTOWB and difficulties in predicting the need in major bleeding, leading to the risk of wastage.
View Article and Find Full Text PDFAnalysis of influencing factors and predictive model construction for platelet transfusion efficacy in hematological patients.
Front Med (Lausanne)
August 2025
Department of Clinical Laboratory, Deyang People's Hospital, Deyang, China.
Background: This study aimed to systematically analyze the independent risk factors for platelet transfusion refractoriness (PTR) in hematological patients, and to develop and validate a nomogram prediction model, thereby providing scientific evidence for personalized platelet transfusion strategies in clinical practice.
Methods: A retrospective cohort study was conducted involving 363 platelet transfusion episodes in hematological patients who received platelet transfusions at Deyang People's Hospital between January 2023 and August 2023. Comprehensive clinical data and laboratory parameters were collected.
Blood component utilization in hospitalized COVID-19 patients: Experience from a dedicated COVID-19 center.
Asian J Transfus Sci
December 2022
Department of Anaesthesia, Pain Medicine and Critical Care, Jai Prakash Narayan Apex Trauma Center, AIIMS, New Delhi, India.
Background: Blood transfusion services were seriously affected during COVID-19 not only due to limited availability of blood components but also due to gap in the clinical knowledge about the need for transfusion in COVID-19 patients. However, understanding the transfusion needs is essential for inventory management. We analyzed the utilization of blood components in hospitalized COVID-19 patients and recorded the outcome of the patients who were transfused.
View Article and Find Full Text PDFReal-world analysis of characteristics and guideline adherence of antiplatelet drugs prescriptions among patients with coronary artery disease and its comorbidities: a cross-sectional study.
BMC Cardiovasc Disord
August 2025
School of Public Health, Shanghai Jiaotong University School of Medicine, 227 Chongqing South RD, Shanghai, 200025, China.
Objectives: To identify the characteristics of antiplatelet drug (APD) prescriptions based on a regional large-scale outpatient database in Shanghai, China, and to compare the practical usage of APDs with the respective clinical guidelines for patients with coronary artery disease (CAD) in China.
Methods: Outpatient electronic healthcare records were extracted from 20 medical institutions in Shanghai from January 2020 to October 2021. Outpatient APD prescriptions among CAD patients and their comorbidity status were analyzed with the χ test.
Aesthetic Treatment Considerations in Patients with Cutaneous Autoimmune Disease.
J Clin Aesthet Dermatol
July 2025
Drs. Mojica, Saikaly, and Gray are with the Department of Dermatology at the University of Florida College of Medicine in Gainesville, Florida.
Objective: The increasing prevalence of autoimmune disease alongside the growing popularity of cosmetic treatments has placed physicians in a unique position to understand how utilizing such treatments can serve as both beneficial and potentially harmful interventions. The objective of this study was to analyze available literature and identify areas where additional research is needed to guide use of facial aesthetic treatments in patients with cutaneous autoimmune disease.
Methods: A literature search was performed on PubMed and Google Scholar for articles describing aesthetic treatments in the setting of autoimmune disease.